Ajanta Pharma reports 85% surge in Q2 net profit

26 Oct 2012 Evaluate

Ajanta Pharma has reported results for second quarter ended September 30, 2012.

The company has registered growth of 84.64% in its net profit after tax at Rs 21.88 crore for the quarter ended September 30, 2012 as compared to Rs 11.85 crore for the same quarter in the previous year. Total income from operation has increased by 37.91% at Rs 186.37 crore for quarter under review as compared to Rs 135.14 crore for the quarter ended September 30, 2011.

Ajanta Pharma (APL) is engaged manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×